Marshall Wace’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-73,905
| Closed | -$798K | – | 2434 |
|
|
2024
Q3 | $798K | Buy |
+73,905
| New | +$798K | ﹤0.01% | 1610 |
|
|
2024
Q1 | – | Sell |
-49,466
| Closed | -$291K | – | 2175 |
|
|
2023
Q4 | $291K | Sell |
49,466
-2,137,832
| -98% | -$12.6M | ﹤0.01% | 1594 |
|
|
2023
Q3 | $21.3M | Buy |
2,187,298
+33,211
| +2% | +$324K | 0.04% | 382 |
|
|
2023
Q2 | $25.5M | Buy |
2,154,087
+344,708
| +19% | +$4.08M | 0.05% | 352 |
|
|
2023
Q1 | $19.5M | Buy |
1,809,379
+328,721
| +22% | +$3.55M | 0.04% | 413 |
|
|
2022
Q4 | $17.1M | Buy |
+1,480,658
| New | +$17.1M | 0.04% | 455 |
|
|
2022
Q3 | – | Sell |
-1,625,817
| Closed | -$14.7M | – | 2629 |
|
|
2022
Q2 | $14.7M | Buy |
1,625,817
+833,833
| +105% | +$7.52M | 0.03% | 575 |
|
|
2022
Q1 | $5.93M | Sell |
791,984
-210,266
| -21% | -$1.57M | 0.01% | 1130 |
|
|
2021
Q4 | $8.6M | Buy |
+1,002,250
| New | +$8.6M | 0.02% | 894 |
|
|
2019
Q1 | – | Sell |
-7,869
| Closed | -$138K | – | 1747 |
|
|
2018
Q4 | $138K | Buy |
+7,869
| New | +$138K | ﹤0.01% | 1319 |
|